Minimally invasive breast biopsy developer Rubicor Medical of Redwood City, CA, reported that Safeguard Scientifics has provided $20 million in growth capital, while ITX International Equity put up $5 million as part of a $30 million Series C financing round.
The firm has three breast biopsy devices that it plans to launch in the near future, and said that all three had received U.S. Food and Drug Administration (FDA) clearance.
By AuntMinnie.com staff writers
August 25, 2006
Copyright © 2006 AuntMinnie.com